Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment

While Harmony Biosciences HRMY may not be a typical cannabis stock involved in cultivation, processing, or sales of marijuana products, it is among the few companies evaluating an investigational cannabidiol (CBD) drug in late-stage development.This Pennsylvania-based company is developing a pharmaceutically manufactured synthetic CBD gel called ZYN-002 as a potential...